CAMPBELL'S BIOLOGY 12E PERUSALL
CAMPBELL'S BIOLOGY 12E PERUSALL
12th Edition
ISBN: 9780135858080
Author: Urry
Publisher: PERUSALL
bartleby

Concept explainers

Question
Book Icon
Chapter 17.1, Problem 1CC
Summary Introduction

To determine: The disorder alkaptonuria is dominant or recessive. Garrod (1902) suggested that this condition is expressed when the faulty gene alleles are inherited from both the parents.

Concept introduction:

Alkaptonuria occurs due to the deficiency of the enzyme homogentisate 1, 2- dioxygenase. Thus, the body is unable to breakdown tyrosine and phenylalanine amino acids causing dark urine. In a research article by Garrod (1902) about alkaptonuria, he suggested that this disorder is caused when the abnormal allele is inherited from both the parents.

Blurred answer
Students have asked these similar questions
COFFEE COFFEE BUZZ BUZZ!!! You've discovered a novel biosynthetic pathway that makes the molecule caffeine.  The pathway can be allosterically inhibited.  Which of the following is mostly likely true. Select one: a. caffeine contains an allosteric site b. caffeine binds to the first enzyme in the pathway c. caffeine can be inhibited by its active site d. the last enzyme inhibits the first enzyme in the pathway e. the first enzyme promotes the degradation of the last enzyme in the pathway
10. Answer ALL parts of this question. Prostaglandin-endoperoxide synthase 2, also known as cyclooxygenase- 2 or COX-2, is an enzyme that in humans is encoded by the PTGS2 gene. (a) Explain how this enzyme facilitates prostaglandin biosynthesis by highlighting two key functions. (b) Describe one role for the COX-1 enzyme. (c) Name one condition that the selective COX-2 inhibitors Vioxx (Rofecoxib) and Celebrex (Celecoxib) were used to treat. (d) Name and draw the chemical structures of 4 other small molecule OCOX-2 inhibitors and identify 3 similarities/common features with respect to Rofecoxib and Celecoxib. (e) Name a therapeutic reason for targeting COX-3. Describe the function and therapeutic utility of non-steroidal anti- (f) inflammatory drugs.
. The allosterically regulated enzyme ATCase binds aspartic acid as a substrate and acylates the a-amino group. Succinate acts as a competitive inhibitor of ATCase because it binds the active site but can't be acylated. The dependence of vo on [aspartic acid] for ATCase is shown in panel (a) of the accompanying figure. Panel (b) shows the effect of increasing [succinate] on v, when [Asp] is held at a low concentration (see thick vertical arrow in panel (a)). Note that in panel (b), vo is not zero when [succinate] =0 (see thin horizontal arrow). Explain the shape of the curve in panel (b). Why does v, increase initially, before decreasing at higher [succinate]? Co0- COO CH2 CH, HC -NH, CH, COO COO Asp Succinate [Asp) [Succinate] [Asp] in experiment b (a) (b)

Chapter 17 Solutions

CAMPBELL'S BIOLOGY 12E PERUSALL

Knowledge Booster
Background pattern image
Biology
Learn more about
Need a deep-dive on the concept behind this application? Look no further. Learn more about this topic, biology and related others by exploring similar questions and additional content below.
Similar questions
SEE MORE QUESTIONS
Recommended textbooks for you
Text book image
Biology: The Dynamic Science (MindTap Course List)
Biology
ISBN:9781305389892
Author:Peter J. Russell, Paul E. Hertz, Beverly McMillan
Publisher:Cengage Learning
Text book image
Biochemistry
Biochemistry
ISBN:9781305577206
Author:Reginald H. Garrett, Charles M. Grisham
Publisher:Cengage Learning